We are venture builders enabling innovation in the healthcare technology space. We build companies from promising early-stage R&D, and provide entrepreneurial and operational support at all the stages of their life cycle to transform pioneering science into healthcare solutions.
We leverage proprietary science to build promising healthcare technology companies from scratch
We attract sources of capital to finance innovation
We provide entrepreneurial and operational support to our companies in order to develop healthcare technologies for the global market
Cube Labs is the first systematic venture builder in the healthcare technology space in Italy, designed to address the gap between the excellent local academic science and the commercially promising life sciences market. We build new companies from leading-edge R&D and enable innovation in order to transform pioneering science into healthcare solutions. From our roots in Italy, we have grown into a pan-European company with a distinguished international management team and a global reach.
Partnerships are the pillars of our operations. Our partnership with the Italian National Institute for Biostructures and Biosystems (INBB), comprising 24 universities, grants us exclusive access to valuable commercial opportunities. We incorporate diverse competences into our organization through our global network. We work together with communities interested in innovation in order to transform outcomes for patients and accelerate the world’s transition to optimal health.
SUCCESSFULLY CONCLUDED THE PLACEMENT AMOUNTING TO € 4,105,000, AT THE OFFER PRICE OF € 2.00 PER SHARE.TRADING TO BEGIN ON 21 MARCH 2023 Rome, March
Rome, March 15th, 2023 – Cube Labs S.p.A. (“Cube Labs” or the “Company”) – an Italian venture builder in the healthcare technology sector – announced